Cytokines and Inflammation: Understanding the Body's Healing Response

Cytokines are small signaling proteins that cells use to communicate with one another, and they sit at the center of how the body responds to injury. A 2025 review in Explorative Immunology describes cytokines as regulating every stage of wound healing — and notes that dysfunction in cytokine production is itself a documented cause of chronic, non-healing wounds. Understanding how these signals work is central to understanding regenerative medicine generally, since so much of the field is built on shaping this signaling environment rather than replacing tissue directly.

The healing process moves through distinct cytokine phases, and the sequence matters as much as the signals themselves. In the initial inflammatory phase, pro-inflammatory cytokines and chemokines — interleukin-1, interleukin-6, and tumor necrosis factor-alpha among them — recruit immune cells to the injury site to clear debris and fight off potential infection. This is a necessary and protective response, not a problem to be eliminated outright.

What distinguishes healthy healing from chronic inflammation is what happens next. As repair progresses, the cytokine environment needs to shift toward anti-inflammatory signals — interleukin-10 and transforming growth factor-beta among the most studied — which allow the process to transition from clearing damage to actually rebuilding tissue: fibroblast proliferation, collagen deposition, and extracellular matrix formation. When that transition fails to happen — when pro-inflammatory signaling persists longer than it should — the result is often a chronic wound that cannot progress past the inflammatory stage.

This is precisely the mechanism that makes MSC-derived secretome of interest in regenerative medicine. A comprehensive 2025 review in the Journal of Advanced Research describes how MSC secretome contains immunomodulatory factors capable of regulating both innate and adaptive immune responses — not simply suppressing inflammation, but helping shift the cytokine environment through the phases healthy healing requires.

The practical takeaway is that "anti-inflammatory" is not automatically the goal, and "pro-inflammatory" is not automatically the problem. Healthy tissue repair needs both phases, in the right order, for the right duration. Understanding cytokine biology this way — as a timed, balanced process rather than a single dial to turn down — is foundational to understanding why regenerative approaches are designed the way they are.